agamree - vamorolone
(Vamorolone)Catalyst Pharmaceuticals, Inc.
3 results
firdapse
(amifampridine phosphate)Catalyst Pharmaceuticals, Inc.Usage: FIRDAPSE® is indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients aged 6 years and older.fycompa
(perampanel)Catalyst Pharmaceuticals, Inc.Usage: FYCOMPA is indicated for treating partial-onset seizures in patients aged 4 and older, and as adjunctive therapy for primary generalized tonic-clonic seizures in patients aged 12 and older.